Human neuroblastoma cell growth in xenogeneic hosts : comparison of T cell-deficient and NK-deficient hosts, and subcutaneous or intravenous injection routes

• Published in: Journal of neuro-oncology 1990-04, Vol.8 (2), p.121-132
• Main Authors: TURNER, W. J. D, CHATTEN, J, LAMPSON, L. A
• Format: Article
• Language: English
• Subjects: Animals; Biological and medical sciences; Humans; Injections, Intravenous; Injections, Subcutaneous; Killer Cells, Natural - immunology; Medical sciences; Mice; Mice, Nude; Neoplasm Metastasis; Neoplasm Transplantation; Neuroblastoma - immunology; Neuroblastoma - physiopathology; Neurology; T-Lymphocytes - immunology; Transplantation, Heterologous - immunology; Tumors of the nervous system. Phacomatoses
• ISSN: 0167-594X; 1573-7373
• DOI: 10.1007/BF00177834

We have examined two features of neuroblastoma cells that had not been well-characterized in a xenogeneic model: The cells display unusual immunologic properties in other experimental systems, and the original tumors display widespread and characteristic patterns of metastasis. To determine the most appropriate immunodeficient host for primary tumor growth, T cell-deficient nude mice, NK-deficient beige mice, beige-nudes, and controls were injected with the well-characterized line CHP-100. To define the pattern of tumor spread, complete autopsies were performed following subcutaneous, intraperitoneal and intravenous injections. CHP-100 consistently formed subcutaneous tumors in T cell-deficient mice (nude and beige-nude), but not in T cell-competent mice (beige, heterozygous nu/+ and bg/+, or wild-type). The growth rate and final size of the subcutaneous tumors were not greater in beige-nudes than in nudes. All mice showed early CHP-100 cell death after subcutaneous injection; the nature of the immunodeficiency was more relevant for the surviving subpopulation. Widespread dissemination was seen following intravenous injection, particularly in beige-nudes. Aspects of the growth patterns were appropriate to the tumor of origin. The behavior in immunodeficient mice suggests that T cells can play a role in controlling the growth of these cells; the next steps will be to define the effector mechanisms, and to determine if they can be exploited for human patients. The hematogenous spread following intravenous injection suggests that insights into the control of blood-borne tumor may also come from further study of this model.